← Home / Johnson & Johnson (JNJ)
Stock Analysis
Johnson & Johnson (JNJ)
JNJ
JNJ · Healthcare • Pharma
258.18 +0.92%
Track JNJ in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when JNJ price is:
52W Range Position
91%
LOWMIDHIGH
Trend
Constructive
Momentum
Neutral
Updated: 2026-07-31 15:45 UTC
WOI Investment Thesis
Constructive
Confirmation improves above 267.24. Holding above 248.66 keeps the current thesis intact.
⚖️
✓
Fundamentals
Improving / Strong
✓
Price Structure
Constructive
•
Momentum
Neutral
×
Breakout Confirmation
Pending
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
248.66
↗
Break Above
Confirmation improves above resistance.
267.24
🎯
Next Objective
Pattern-derived target if setup continues.
—
×
Thesis Break
Scenario weakens below invalidation.
Below 248.66
Recent Company Events
SEC VERIFIED
Latest material filings
JUL
15
●
Financial Results
HIGH
Johnson & Johnson reports Q2 2026 results, raises 2026 outlook
• 2026 Second-Quarter reported sales growth of 6.6% to $25.3 Billion with operational growth of 5.6%* and adjusted operational growth of 5.7%* • 2026 Second-Quarter earnings per share (EPS) of $2.27 and adjusted EPS* of $2.90 • Strong operational performance results in the Company increasing 2026 guidance with estim...
8-K Filing • SEC EDGAR
What's Driving JNJ?
📈 Technical recovery is improving
Momentum is Neutral. Watch 267.24 for confirmation and 248.66 for structure risk.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Below 248.66
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
No confirmed breakout yet. Watch the next level and momentum behavior.
RSI(14)
53.9
◎
How to read this setup
The next meaningful technical decision is likely to occur between support at 248.67 and resistance at 259.54. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis.
Price Chart
JNJ — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-07-30
Fair
Fair valuation
Valuation looks broadly balanced for a mature quality business.
Market Cap
$624.2B
Company size
EV
$656.9B
Debt-adjusted value
P/E
29.7
Reasonable
P/S
6.4
Balanced
P/B
7.3
Balanced
EV/Sales
6.7
Balanced
EV/EBIT
30.4
Reasonable
P/FCF
28.1
Reasonable
FCF Yield
3.56%
Cash return
Source: SEC TTM data via WOI valuation cache Not financial advice
Business Lens
Strong financial quality
Revenue and profitability remain supportive, while cash flow and balance sheet quality require monitoring.
↗
Revenue Growth
Improving
●
Profitability
Strong
≈
Cash Flow
Healthy
⚖
Balance Sheet
Manageable
💵 Revenue
25.31B
↗ Improving
📈 Net Income
5.53B
↗ Strong
🧮 EPS (Basic)
2.30
↗ Strong
Johnson & Johnson
Healthcare • Pharma
Related Opportunities